Seeing Is Believing
AMPH is currently covered by 3 analysts with an average potential upside of $3.79 (23.73%) backed by displayed 50 price targets and 51 ratings.
Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 308.88 days.
Highest price target for AMPH is 43, Lowest price target is 23, average price target is 33.
Most recent stock forecast was given by JACOB HUGHES from WELLS FARGO on 17-May-2023. First documented stock forecast 25-Mar-2015.
Currently, out of the existing stock ratings of AMPH - 6 which are a Buy (66.67%), 3 which are a Hold (33.33%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
44
$-10.41 (-19.13%)
40
6 months 13 days ago
5/5 (100%)
$1.09 (4.36%)
86
Buy
41
$-13.41 (-24.65%)
40
8 months 29 days ago
10/10 (100%)
$4.72 (22.69%)
390
Buy
33
$-21.41 (-39.35%)
24
1 years 8 months 19 days ago
3/3 (100%)
$2.91 (17.37%)
375
Hold
18
3 years 4 months 21 days ago
1/1 (100%)
$5.8 (47.54%)
115
Hold
21
3 years 6 months 19 days ago
8/8 (100%)
$0.82 (5.67%)
191
What is AMPH (Amphastar Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on AMPH (Amphastar Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on AMPH (Amphastar Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on AMPH (Amphastar Pharmaceuticals)?
Which analyst is the currently most bullish on AMPH (Amphastar Pharmaceuticals)?
Which analyst is the currently most reserved on AMPH (Amphastar Pharmaceuticals)?